NHS52S04
NHS52S04: Ultra-Low-Power Bluetooth® Low Energy Solution With Arm® Cortex®-M33 TrustZone® for Medical IoT
Step Forward
Advancing An Automated Insulin Delivery System With Insulet
Featured in This Video
Key Highlights
Key Highlights
- Real-Time Insulin Automation: Enables real-time, automated insulin delivery by supporting predictable on-device processing and continuous system responsiveness as glucose levels change.
- Integrated CGM Connectivity: Supports reliable, low-latency communication with continuous glucose monitoring (CGM) systems to enable secure, synchronized data exchange and accurate insulin dosing.
- Low-Power Wearable Performance: Optimized for energy-efficient operation within a compact, body-worn device, enabling continuous functionality throughout the day and night without compromising performance.
- Trusted and Secure Operation: Ensures trusted system operation and protects system integrity through integrated, device-level hardware security for every command and data exchange.
Knowledge Base
Knowledge Base
NHS52S04 Wireless MCU
An ultra-low-power Bluetooth® Low Energy 5.3 solution integrating an Arm® Cortex®-M33 microcontroller, wireless transceiver and flash on a single chip. It enables compact system design and supports continuous operation in wearable medical devices.
Integrated Hardware Security
Built-in security features include Arm® TrustZone®, secure boot, cryptographic acceleration (AES, RSA, ECC and PUF-based key storage). These mechanisms help protect system integrity and secure device communication.
Bluetooth® Low Energy Connectivity
Low-power wireless technology that enables reliable communication between insulin delivery systems and continuous glucose monitoring (CGM) devices for real-time data exchange.
Edge Processing Architecture
On-device data processing that enables predictable, real-time system responsiveness, reduces latency and limits reliance on external or cloud-based systems.
Featured Customer
Insulet
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone or the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.